References
- Woodson R E, Youngken H W, Schlittler E, Schneider J A. Rauwolfia: Botany, Pharmacognosy, Chemistry and Pharmacology. Brown and Company, Boston 1957; 149
- Robbers J E, Speedie M K, Tyler V E. Pharmacognosy and Pharmacobio-technology. Williams & Wilkins, Baltimore 1996; 337
- Tyler V. E. The Herbal Market in the United States Today. Lloydiana 1999; 4(4)2–4
- RFS. Drug Industry Looks to the Lab Instead of Rainforest and Reef. Science 1999; 285: 186
- Mueller H. Natural Products and Their Importance in Drug Discovery. 2000 Years of Natural Products Research: Past, Present and Future, T Luijendijk, P de Graf, A Remmelzwaal, R Verpoorte. University of Leiden, Division of Pharmacognosy, Leiden 1999; L05
- Baerheim Svendsen A. Biogene Arzneistoffe -heute noch oder heute wieder?. Biogene Arzneistoffe, F-C Czygan. Friedr. Vieweg & Sohn, Braunschweig 1984; 27–39
- Teuscher E. Zur möglichen Funktion von Sekundärstoffen in biologischen Systemen. Biogene Arzneistoffe. Friedr. Vieweg & Sohn, Braunschweig 1984; 61–83
- Hartmann T. Pyrrolizidine Alkaloids Between Plants and Insects: Present State and Future Perspectives. Op.cit., T Luijendijk, P de Graf, A Remmelzwaal, R Verpoorte, L68
- Tyler V. E. Natural Products and Medicine: An Overview. Medicinal Resources of the Tropical Forest, M J Balick, E Elisabetsky, S A Laird. Columbia University Press, New York 1996; 3–10
- Van Matre L. The Healing Forests. Chicago Tribune March, 1994; 15 1–2
- Mendelsohn R, Balick M J. The Value of Undiscovered Pharmaceuticals in Tropical Forests. Econ Bot 1995; 49: 223–228
- Anon. Fears for Amazon Forest. New York Times August, 1999; 18: A4
- Sittenfeld A. Tropical Medicinal Plant Conservation and Development Projects: The Case of the Costa Rican National Institute of Biochemistry (INBio). Op.Cit., M J Balick, E Elisabetsky, S A Laird, 334–340
- Tamayo-Castillo G. Biodiversity Prospecting: An Essential Component in the Conservation Strategy. Op.cit., T Luijendijk, P de Graf, A Remmelzwaal, R Verpoorte, L53